CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer

BACKGROUND: CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6), a programmed death-ligand 1 (PD-L1) regulator, is widely expressed in various tumors and regulates the immune microenvironment. However, its prognostic value remains controversial, and the roles of CMTM6 in colorectal cancer (CR...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunother Cancer
Päätekijät: Peng, Qi-Hua, Wang, Chun-Hua, Chen, Hong-Min, Zhang, Rong-Xin, Pan, Zhi-Zhong, Lu, Zhen-Hai, Wang, Gao-Yuan, Yue, Xin, Huang, Wenlin, Liu, Ran-Yi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Immunotherapy Biomarkers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883863/
https://ncbi.nlm.nih.gov/pubmed/33579737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001638
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia